| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphodiesterase 4B | 0.566 | 0.731 | 0.47 |
|
disease | 0.500 | None | 0.957 | 3 | 2 | 2005 | 2019 | ||||||||
|
glutamate ionotropic receptor AMPA type subunit 1 | 0.570 | 0.577 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 2 | 1995 | 2019 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.948 | 2 | 2 | 2002 | 2020 | ||||||||
|
nitric oxide synthase 1 adaptor protein | 0.608 | 0.423 | 0.61 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2005 | 2018 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1997 | 2017 | ||||||||
|
bromodomain containing 1 | 0.644 | 0.654 | 1.00 |
|
disease | 0.500 | None | 0.800 | 1 | 1 | 2006 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.500 | None | 0.750 | 1 | 1 | 2006 | 2019 | ||||||||
|
solute carrier family 1 member 1 | 0.561 | 0.654 | 8.7E-06 |
|
disease | 0.500 | None | 1.000 | 1 | 2 | 2001 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.859 | 1 | 1 | 1997 | 2019 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1997 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 7 | 1996 | 2017 | ||||||||
|
forkhead box P2 | 0.545 | 0.808 | 1.00 |
|
disease | 0.500 | None | 0.800 | 1 | 1 | 2005 | 2019 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.500 | None | 0.900 | 0 | 0 | 2003 | 2019 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
disease | 0.500 | None | 0.965 | 0 | 0 | 2002 | 2018 | ||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2001 | 2010 | |||||||||
|
proline dehydrogenase 1 | 0.612 | 0.692 | 5.4E-12 |
|
disease | 0.500 | None | 0.955 | 0 | 0 | 2004 | 2018 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.500 | None | 0.841 | 0 | 0 | 1992 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.887 | 0 | 0 | 1984 | 2020 | ||||||||
|
mediator complex subunit 12 | 0.476 | 0.769 | 1.00 |
|
disease | 0.490 | None | 0.800 | 0 | 0 | 2000 | 2010 | ||||||||
|
synapsin II | 0.653 | 0.577 |
|
disease | 0.490 | None | 0.889 | 0 | 0 | 2000 | 2019 | |||||||||
|
VRK serine/threonine kinase 2 | 0.722 | 0.269 | 1.6E-11 |
|
disease | 0.480 | None | 1.000 | 8 | 6 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.480 | None | 0.500 | 3 | 5 | 1993 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.480 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.470 | None | 0.500 | 3 | 8 | 2002 | 2019 | ||||||||
|
nudE neurodevelopment protein 1 | 0.608 | 0.462 | 6.7E-03 |
|
disease | 0.470 | None | 1.000 | 1 | 1 | 2007 | 2019 |